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(57) 	 ABSTRACT 
A model of tissue is produced by steps comprising seeding 
cells at a selected concentration on a support to form a cell 
spot, incubating the cells to allow the cells to partially attach, 
rinsing the cells to remove any cells that have not partially 
attached, adding culture medium to enable the cells to prolif-
erate at a periphery of the cell spot and to differentiate toward 
a center of the cell spot, and further incubating the cells to 
form the tissue. The cells may be C2C12 cells or other sub-
clones of the C2 cell line, H9c2(2-1) cells, L6 cells, L8 cells, 
QM7 cells, So18 cells, G-7 cells, G-8 cells, other myoblast 
cells, cells from other tissues, or stem cells. The selected 
concentration is in a range from about 1 x 10 5 cells/ml to about 
1 x10 6 cells/ml. The tissue formed may be a muscle tissue or 
other tissue depending on the cells seeded. 
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G. 9 
SFED CE-LLSTO FORLM A HIGH 	 92 
DENSITY SPOT IN A TISSUE 
CULTURE DISH 
ALLOW THE CELLS TO 
PROLIFERA-TE ATTHE 
PERIPHERY OF THE CELL. SPOT 
AND TO DIFFERENTIATE FROM 
THE CENTER OF THE CELL SPOT 
ALLOW 'THE DIFFERENTIATED 
CEILLSTO ALIGN A NND FORM-1. 
MULTINUCLEATED MYOTUBES 
90 
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HIGH-DENSITY SPOT SEEDING FOR TISSUE 	 BRIEF DESCRIPTION OF DRAWINGS 
MODEL FORMATION 
CROSS REFERENCE TO RELATED 
APPLICATION 
This is a divisional application of application Ser. No. 
12/880,602 filed on Sep. 13, 2010. 
ORIGIN OF THE INVENTION 
The inventions claimed herein were made in the perfor-
mance of work under a NASA contract and is subject to 
Public Law 96-517 (35 U.S.C. §200 et seq.). The contractor 
has not elected to retain title. 
BACKGROUND OF INVENTION 
Field of the Invention 
The invention relates generally to methods for culturing 
cells to form tissue models, particularly models of muscle 
tissue. 
SUMMARY OF INVENTION 
One embodiment described herein relates to a method for 
culturing cells to form tissue comprising the steps of seeding 
cells at a selected concentration on a support to form a cell 
spot, incubating the cells to allow the cells to initially or 
partially attach to the form a cell spot, incubating the cells to 
allow the cells to initially or partially attach to the support, 
rinsing the cells gently after initial or partial attachment to 
remove any cells that are unattached, adding growth medium 
to the support, after rinsing such that the attached cells pro-
liferate about a periphery of the cell spot, and further incu-
bating the cells to form tissue. The cells may be myoblasts 
(i.e., immature muscle cells) such as C2C12 cells or other 
subclones of the C2 cell line, H9c2(2-1) cells, L6 cells, L8 
cells, QM7 cells, So18 cells, G-7 cells, G-8 cells, other myo-
blast cells, cells from other tissues, stem cells, or de-differ-
entiated cells. The selected concentration for the above cells 
is in a range from about 1 x10 5 cells/ml to about 1 x10 6 cells/ 
ml. The resulting tissue may be skeletal muscle tissue, cardiac 
muscle tissue, nerve tissue, or bone tissue. 
Another embodiment described hereinrelates to tissue pro-
duced by the steps of seeding cells at a selected concentration 
on a support to form a cell spot, incubating the cells to allow 
the cells to partially attach to the support, removing any cells 
that are unattached after this step of incubating, adding 
growth medium to the support after removing the unattached 
cells such that the cells proliferate about the periphery of the 
cell spot, and additional incubating of the cells to enable 
tissue formation. The cells may be myoblasts such as C2C12 
cells or other subclones of the C2 cell line, H9c2(2-1) cells, 
L6 cells, L8 cells, QM7 cells, So18 cells, G-7 cells, G-8 cells, 
other myoblast cells, cells from other tissues, stem cells, or 
de-differentiated cells. The selected concentration for the 
above cells is in a range from about 1x10 5 cells/ml to about 
1 x10 6 cells/ml. The resulting tissue may be skeletal muscle 
tissue, cardiac muscle tissue, nerve tissue, or bone tissue. 
Other aspects and embodiments described herein will be 
apparent from the following description and the appended 
claims, taken in conjunction with the accompanying draw-
ings, illustrating the principles of the embodiments by way of 
example only. 
FIG. 1 shows a schematic illustrating a method of high-
density spot seeding (HDSS) in accordance with embodi-
5 ments described herein. 
FIG. 2 shows a schematic illustrating a close-up view of a 
single cell spot in accordance with an embodiment described 
herein. 
FIG. 3 shows a schematic illustrating alignment of new 
to cells at the periphery of a single cell spot one hour after 
seeding in accordance with an embodiment described herein. 
FIGS. 4A-C show schematics illustrating the progression 
of cell growth by proliferation and alignment of cells at the 
periphery of a cell spot 24-48 hours after seeding in accor- 
15 dance with an embodiment described herein. 
FIG. 5 shows a schematic illustrating formation of myo-
tubes in a cell spot about 72 hours after seeding in accordance 
with an embodiment described herein. 
FIG. 6 shows a microscopic image of aportion of a cell spot 
20 about 8 days after seeding in accordance with an embodiment 
described herein. 
FIG. 7 shows a comparison of myotube alignments pro-
duced by serum-induced myotube culture (left panel) and by 
a method in accordance with an embodiment described herein 
25 (right panel). 
FIG. 8 shows a comparison of myotube alignments 
induced by using poly-(L-lactic acid) PLLA nanofiber pat-
terning (left panel) and by a method in accordance with an 
embodiment described herein (right panel). 
30 	 FIG. 9 is a block diagram representative of a method for 
forming a model of muscle tissue in accordance with an 
embodiment described herein. 
DETAILED DESCRIPTION OF EXEMPLARY 
35 	 EMBODIMENTS 
Exemplary embodiments will now be described with ref-
erence to the accompanying drawings. Like elements or com-
ponents in the drawings are denoted with the same reference 
40 characters for consistency. 
The exemplary embodiments described herein relate to 
methods for producing or forming models of tissue, such as 
models of muscle tissue. Such methods comprise the act of 
high-density seeding, which may be described as "spot seed- 
45 ing", of progenitor cells, followed by incubating the cells to 
allow the cells to proliferate, align, fuse and differentiate into 
mature tissues. Although the following description uses a 
skeletal muscle cell line as one example, one of ordinary skill 
in the art would appreciate that the embodiments described 
5o herein also relate to other cell types, such as nerve cells, bone 
cells, and cardiac muscle cells, or other anchorage-dependent 
cells. 
For example, for skeletal muscle tissue, one can utilize any 
commercially available skeletal muscle progenitor cells. In 
55 accordance with one embodiment, immature muscle cells are 
seeded into a spot at a relatively high density. Next, the cells 
are incubated under conditions to allow the cells to prolifer- 
ate, align, fuse, and mature into functional muscle tissue 
models. The skeletal muscle tissue models of the embodi- 
60 ments described herein may be used to study various pro- 
cesses involved in skeletal muscle maturation, such as prolif- 
eration, alignment, fusion (to form multinucleated cells), 
differentiation (production of new proteins necessary for con- 
traction), and contraction. These models can help in the 
65 understanding of the mechanism of muscle atrophy and 
facilitate the development of methods or reagents to alleviate 
or prevent muscle atrophy. In addition, such models of muscle 
US 9,243,223 B2 
3 
	
4 
tissue may find use in the treatment or repair of muscle dam-
age, such as in muscle atrophy, skeletal muscle trauma (i.e., 
burns), or muscle damage resulting from cardiac infarction. 
In one example described herein, C2C12 cells are used, 
which are available from the American Type Culture Collec-
tion (ATCC) Cell Repository Line (CRL)-1772. C2C12 cells 
are mouse myoblastic precursor cells. Other muscle precur-
sor cell types (myoblasts) may also be used without departing 
from the scope of the claims appended hereto, such as, H9c2 
(2-1) cells (ATCC CRL-1446), L6 cells (ATCC CRL-1458), 
L8 cells (ATCC CRL-1769), QM7 cells (ATCC CRL-1962), 
So18 cells (ATCC CRL-2174), G-7 cells (ATCC CRL-1447), 
and G-8 cells (ATCC CRL-1456). 
Methods in accordance with embodiments described 
herein make use of high-density seeding of myoblasts to 
induce alignment, fusion, and differentiation of the cells into 
muscle tissue models. High-density seeding likely prevents 
cells from flattening in most areas of the spot of seeding 
except the periphery of the spot. The round cells in the center 
of the spot have increased cell-cell contacts, which induce 
expression of genes that cause the cells to switch from a 
proliferating phenotype to a differentiating phenotype. That 
is, cells originally positioned in the center of a spot are less 
able to further divide, due to cell contact inhibition, than cells 
originally positioned along the periphery of a spot, which are 
able to flatten and continue to proliferate. 
As growth of cells continue from the spot of seeding, newly 
formed cells become spatially limited by adjacent newly 
formed cells and, therefore, newly formed cells are forced to 
align outward in a consistent manner. As more and more cells 
proliferate, less space is available. Cells become crowded and 
experience increased cell-cell contacts as they grow. As men-
tioned above, the increased cell-cell contacts cause the cells to 
switch from the proliferating phenotype to the differentiating 
phenotype. Thus, a timeline is established with the youngest 
cells (proliferating cells) at the periphery of the growing spot 
and the more mature cells (differentiated cells) away from the 
periphery and toward the center of the spot of initial seeding. 
Referring now to the appended drawings, FIG.1 illustrates 
a method of high-density spot seeding (HDSS) in accordance 
with one embodiment. Cells may be seeded as one or more 
"high-density" spots 10 in a culture plate 12 (with or without 
a coating) or other suitable support. The seeding may be 
performed with an appropriate "high density" for the type of 
cells selected, such high density normally being within a 
range from about 1 x10 5 cells/ml to about 1 x 10 6 cell/ml. In an 
embodiment for C2C12 cells, "high density" is around 5 x10 5 
cells/ml, with the volume of each spot being within a range of 
about 20 ld to about 50 µl. More than one high-density spot 
may be seeded in culture plate 12 depending on the desired 
applications after formation of the tissue. For example, a few 
spots (e.g., 4-6 spots) may be introduced in a 100 mm tissue 
culture plate. 
Because the concentration of the cells in a high-density 
spot is relatively high (as compared to the broad spectrum of 
density seeding techniques known to the skilled artisan), cells 
in each spot are in contact with each other, except for the area 
along the periphery of the spot. To illustrate the positioning of 
the plurality of cells in a "high-density" spot (although not 
necessarily to scale). FIG. 2 shows a close-up view of a 
plurality of cells clustered together in high-density spot 10 
shortly after the initial step of seeding. 
As noted above, cells at the periphery of spot 10 are not 
prevented from flattening outward. As a result, cells at the 
periphery will elongate outwardly after some time. FIG. 3 is 
a graphical representation of a close-up view of spot 10 after 
an initial or partial attachment period of about one hour after 
seeding. Cells 30 at the periphery exhibit a flattened morphol-
ogy, while cells 32 in the center of spot 10 maintain a more 
rounded appearance. Rounded cells 32 in the center of spot 10 
have more cell-cell contacts, which would induce expression 
5 of genes that cause the cells to switch from a proliferating 
phenotype to a differentiating phenotype. After this initial or 
partial attachment period, the cells at this stage are rinsed by 
gently adding culture medium. The act of rinsing removes 
loosely attached or unattached cells and eliminates them from 
to the culture plate 12. The act of rinsing prevents cells from 
later dislodging from spot 10 and settling into non-spot areas. 
Thus, the act of rinsing helps keep large areas unobstructed by 
other cells, permitting the proliferating cells to grow in a 
15 direction outward from the center of spot 10 into unoccupied 
areas of the culture vessel and thereby align. Alignment is a 
functional requirement of skeletal muscle cells. 
After rinsing and aspiration of the culture medium and 
unattached cells, additional culture (growth) medium is 
20 added to the culture plate. For a 100 mm Petri dish serving as 
the culture plate, the range of volume of additional culture 
medium added is about 10 ml to about 30 ml. The volume of 
culture medium at this stage of the process should be a suffi-
cient amount of medium such that the cells may be left alone 
25 without adding more culture medium thereafter for a period 
of about 13 days. Further, the volume of additional culture 
medium should be less than what overfills the culture plate 12 
so as to avoid spilling of medium during movement of the 
culture plate. The medium used may be the same growth or 
30 culture medium used originally during the initial step of seed-
ing and need not be a differentiation medium that promotes 
cell differentiation. 
Referring now to FIGS. 4A-C, a progression of the growth 
of the plurality of cells seeded in an exemplary spot 10 is 
35 shown as snapshots proceeding in time (from left to right) 
from about 24 to about 48 hours after initial seeding. As 
shown in FIG. 4A, new cells 40 are produced from the origi-
nal cells at the periphery of spot 10. FIG. 4B shows that after 
more incubation, these new cells 40 begin to flatten to become 
40 flattened, proliferating cells 42. As new cells are continually 
produced, they eventually flatten and are forced to align in an 
outward direction, as shown in further progression in FIG. 
4C. The continuing production, flattening, and alignment of 
new cells gradually increases the size of the spot. 
45 	 FIG. 5 is a close-up illustration of a portion of the cells of 
an exemplary spot 10 at about 72 hours after seeding. Spon-
taneous differentiation of the cells can be observed at this 
stage without the act of switching or altering the serum used 
as the growth medium. In particular, small myotubes 50, 
50 which result from fusion of the myoblasts, are observed near 
the center (mature area) 52. Fewer myotubes are observed 
towards the periphery area 54, and no myotubes are seen at 
the actively proliferating periphery. 
FIG. 6 is a microscopic image of a portion of an exemplary 
55 spot 10 about 8 days after seeding. In this image, formations 
of multinucleated myotubes 60 are shown. The elongated 
multinucleated myotubes 60 are outlined by the dotted lines 
in the image. 
FIG. 7 shows a comparison between myotubes produced 
6o by a method known in the related art (serum induction/dep- 
rivation) on the left panel and myotubes formed by high- 
density spot seeding in accordance with at least one embodi- 
ment herein described and appearing on the right panel of the 
drawing. Note that the myotubes on the right panel are well 
65 aligned. In contrast, the myotubes visible on the left panel, 
formed by the method of the related art known as serum 
induction/deprivation, did not generate well-aligned myo- 
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tubes. The drawing suggests that myotubes produced by the 
method herein described mimic natural muscle tissues. 
FIG. 8 provides a comparison betweenmyotubes shown on 
the left panel that are produced by another method known in 
the related art, using PLLA. (poly L-lactic acid) nanofiber 5 
scaffolding and modified by the techniques described in the 
publication of Ngan Huang, et al., entitled "MyotubeAssem-
bly on Nanofibrous and Micropatterned Polymers," pub-
lished in Nano Lett. 2006, Mar. 8; 6: 537-542, and myotubes 
shown on the right panel that are produced by high-density 10 
spot seeding in accordance with embodiments described 
herein. Again, the myotubes formed by the method herein 
described are well aligned. In contrast, the alignment of myo-
tubes formed in the presence of PLLA nanofiber scaffolding 
is controlled by how well the nanofibers are aligned. 15 
FIG. 9 is a block diagram representative of a method for 
forming a model of muscle tissue in accordance with an 
exemplary embodiment described herein. Method 90 may 
start with the step of seeding a plurality of cells to form one or 
more high-density cell spots in a tissue culture plate or a 20 
similar support (step 92). The tissue culture plate or similar 
support may be modified by coating with one or more extra-
cellular matrix components and/or one or more adhesion 
proteins, wherein the extracellular matrix components may 
be selected from the group consisting of collagens, laminins, 25 
fibronectins, elastins, keratins, heparin sulfates, chondroitin 
sulfates, keratin sulfates, or hyaluronic acid, and wherein the 
adhesion proteins may be selected from integrins or cad-
herins. The plurality of cells needed for seeding may be from 
commercial sources (e.g., ATCC) and grown in a manner 30 
known by one of ordinary skill in the art to obtain a sufficient 
high density before the step of spot seeding. For example, 
cells may be grown in culture in a flask and harvested by 
chemical detachment and centrifugation. Cells may be grown 
in an appropriate medium, such as a proliferation (i.e., 35 
growth) medium. Seeding for high density is within a range of 
from about 1x105 cells/ml to about 1x10 6 cells/ml. A cell 
density of about 5x10 5 cells/ml for C2C12 cells was used in 
the method of the Example described in more detail below. 
After the cells have attached to the tissue culture dish (or 40 
other support) and the unattached cells are washed off by 
rinsing, additional growth medium is added such that the cells 
are allowed to grow in the support for an undisturbed period 
of time of days that are nearly two weeks long. Cells at the 
periphery of the spot proliferate, while cells near the center of 45 
the spot, due to contact inhibition, do not further proliferate 
but instead tend to differentiate into mature cells (step 94). 
The immature cells are allowed to align, fuse to form multi-
nucleated myotubes, and differentiate into mature muscle 
tissues (step 96). 50 
Example 
Embodiments previously described will now be illustrated 
with an example using a plurality of C2C12 cells to provide 55 
further details of how to form a model of muscle tissue. 
First, C2C12 cells are grown or cultivated in tissue culture 
plates. The cells are grown using a culture or growth medium, 
such as Dulbecco's Modified Eagle's Medium (DMEM) and 
10% fetal calf serum. The expanded cells are then detached 60 
from the culture plates using trypsin (e.g., 0.25% (w/v) 
trypsin and 0.53 mM EDTA solution). The detached cells are 
then collected by centrifugation. The collected cells are re-
suspended in fresh culture medium at an appropriate high 
density, such as the range of about 1x10 5 cells/ml to about 65 
1 x10 6 cells/ml. In this example, the cell density chosen was 
about 5x105 cells/ml. The preparation procedures are tech- 
6 
piques known by the skilled artisan, such as, for example, 
procedures recommended by the ATCC. Obtaining the appro-
priate density is a matter of diluting or further concentrating 
the cells via additional acts of centrifugation and/or aspira-
tion. 
Using the cell stock suspension, C2C12 cells are seeded to 
form high-density spots on a support such as a tissue culture 
plate (e.g., a 100 mm Petri dish) that has been sterilized and 
treated (i.e., coated) with one or more extracellular matrix 
components and/or one or more adhesion proteins so as to 
provide a cell growth surface of attachment with uniform 
chemistry. An example of such a culture plate is the BD 
FalconTM cell culture dish sold commercially by the vendor 
BD Biosciences. The spotting should be performed using 
aseptic techniques. For each spot, about 50 ld of cells are 
dispensed and transferred to the plate. Typically, this volume 
may form a spot having a diameter of about 1 to about 1.5 cm 
in the 100 mm dish. More than one high-density spot may be 
dispensed and positioned within the dish, with sufficient 
spacing from one another so as to permit growth along each 
spot's periphery without immediate contact to another high-
density spot. For example, about 4 to about 6 spots in total 
may be spaced apart from one another in a 100 mm Petri dish. 
The manner of roughly even spacing of each spot of high-
density seeding from one another is exemplified in FIG. 1. 
The C2C12 cells are then allowed to initially or partially 
attach to the interior cell growth surface within the dish by 
incubating the plurality of cells at 37° C. for 1-2 hours. 
Afterwards, the unattached cells are washed off by gently 
adding 10 ml of 37° C. culture medium to one side of the Petri 
dish, followed by swirling of the dish. Care should be taken to 
avoid adding media directly onto the one or more spots, which 
has the potential of washing semi-attached cells off from the 
center of the one or more spots. The culture medium and 
unattached cells are then removed by aspiration. 
Next, thirty (30) ml of proliferation (i.e., growth) medium 
are added to the Petri dish, and the dish is covered and incu-
bated at 37° C. After 3 days of incubation, myotubes start to 
appear. A tissue model having a differentiation "time-line" 
can be seen at this time. Proliferating cells are observed 
aligned at the periphery of the enlarged cell spots, and myo-
tubes are observed extending from tear the center of the cell 
spots toward the periphery of the cell spots, as represented in 
the drawing of FIG. 5. 
During this period of incubation, the cells are monitored by 
visual inspection daily, but culture vessels are left largely 
undisturbed. Culture media may be aspirated and replaced as 
needed. Subsequent medium changes, if they occur, should be 
about 10 ml of medium for a 100 ml dish. This step of media 
aspiration and replacement was not necessary (normally) 
until or near Day 13 of incubation. One skilled in the art will 
readily acknowledge a circumstance in which the culture 
media should be changed. For example, a skilled artisan 
might recognize that the culture media should be replaced 
based on color changes in a substance known as phenol red 
that is added to the media. The phenol red serves as an indi-
cator of nutrient depletion and of an increase in acidity of the 
medium. Fresh medium that has phenol red added is typically 
rose red in color, whereas spent medium approaches yellow. 
A change of medium was performed if the color became 
orange. The one or more spots continued to grow in size 
outwardly and began to join other spots depending on the 
number of cell spots originally seeded and the original 
amount of distance between them. 
By the thirteenth day of incubation, aligned, spontaneously 
contracting myotubes are observed. More myotubes with pro-
nounced contractions are observed where two cell spots meet 
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and j oin. The cells are maintained for an additional two weeks 
by daily replacement of fresh culture media. Many mature 
myotubes are observed to exhibit synchronized spontaneous 
contraction. 
The above described example is an exemplary embodiment 
illustrating the manner and process of how to seed a high-
density spot of a plurality of cells, how to allow the cells to 
proliferate from the periphery of the spot, and how to allow 
the cells to align, fuse, and differentiate. Methods of the 
exemplary embodiments described herein are based on a 
well-established cellular mechanism, i.e., contact inhibition, 
which is common with most anchorage dependent cell types. 
A person of ordinary skill in the art would appreciate, after 
having the benefit of the detailed description contained 
herein, that the above procedures may also be used, with little 
or no modifications, for other human or animal cell types that 
are anchorage dependent, such as cardiac muscle cells, bone 
cells, and nerve cells. Methods in accordance with the 
embodiments described herein may also be applied to cultur-
ing stem cells or de-differentiated cells. 
In accordance with another embodiment, a method for 
forming a three-dimensional tissue model is described. For 
this embodiment, each monolayer of tissue model that would 
be formed by the method of high-density spot seeding previ-
ously described above may be stacked upon another mono-
layer using a lamination process in which a layer of extracel-
lular matrix component (e.g., collagen, laminin, fibronectin, 
elastin, etc.) is positioned in between the two monolayers of 
tissue model. The resulting laminated tissue model would be 
three-dimensional. Alternatively, in yet another embodiment, 
other types of different cell types may also be formed using 
the method of high-density spot seeding, and each monolayer 
of tissue model formed may be stacked upon the other type(s) 
of tissue model(s). For example, monolayer models of nerve 
tissue or blood vessel tissue may be incorporated onto mono-
layer models of muscle tissue to produce a model tissue 
system having interacting tissue models. The methods 
described herein may enable formation of small pieces of 
tissue to be engineered for use in clinical applications in the 
field of regenerative medicine. 
The embodiments directed to methods may be utilized to 
form tissue models, another exemplary embodiment, such as 
aligned, spontaneous contracting myotubes without the use 
of special medium, or without (costly, time-consuming) spe-
cialized substrates to induce cell alignment. The methods 
describe simple, reproducible, and cost-effective ways for 
making two-dimensional or three-dimensional tissue models. 
Such tissue models may have biomedical and regenerative 
applications, including tissue patching or repair using trans-
plantable tissues, such as bone, skeletal muscle, and cardiac 
muscle. 
Moreover, when combined with other cell culturing tech-
niques, such as gene silencing, knock-up/knock-down of 
genes/proteins, and dominant negative mutants, the tissue 
8 
models and differentiation "time-lines" generated by the 
methods of the embodiments may serve as powerful tools to 
elucidate the underlying mechanisms of cell differentiation, 
muscle atrophy, and molecular events associated with muscle 
5 contraction. 
Although only a few exemplary embodiments of the inven-
tion have been described in detail above, those skilled in the 
art will readily appreciate that many modifications are pos-
sible in the exemplary embodiments without materially 
10 departing from the novel teachings and advantages of this 
invention. Accordingly, all such modifications are intended to 
be included within the scope of this invention as defined in the 
following claims. In the claims, means-plus-function and 
step-plus-function clauses are intended to cover the structures 
15 or acts described herein as performing the recited function 
and not only structural equivalents, but also equivalent struc-
tures. Thus, while a nail and a screw may not be structural 
equivalents in that a nail employs a cylindrical surface to 
secure wooden parts together, whereas a screw employs a 
20 helical surface, in the environment of fastening wooden parts, 
a nail and a screw may be equivalent structures. 
The invention claimed is: 
1. A three-dimensional model of muscle tissue produced by 
steps comprising: 
25 	 seeding anchorage-dependent cells onto a support to form 
a cell spot, the cells having a range of concentration of 
from about 1x105 to about 1x10 6 cells per milliliter of 
culture medium, with the volume of each spot being 
within a range of about 20 ld to about 50 µl, wherein the 
30 anchorage-dependent cell is a cell that can be induced 
into a muscle cell; 
incubating the cells for an initial period of time to allow the 
cells to partially attach to the support; 
removing any cells that have not partially attached to the 
35 	 support after the initial period of time of incubation; 
adding growth culture medium to the support after remov-
ing the unattached cells such that the partially attached 
cells proliferate about a periphery of the cell spot and 
differentiate away from the center of the cell spot, 
40 wherein the amount of growth culture medium added is 
a volume sufficient to enable the partially attached cells 
to proliferate undisturbed and without culture medium 
refresh for a period of time of at least seven days; 
further incubating the cells to form a first layer of muscle 
45 	 tissue, wherein further incubating causes the cells to 
align, fuse and mature into functional muscle tissue; 
making a second layer of muscle tissue, made in the same 
manner as the first layer of muscle tissue; 
positioning the second layer of muscle tissue on top of the 
50 first layer of muscle tissue; and 
positioning a layer of extracellular matrix component in 
between the first layer and the second layer of muscle 
tissue to produce a three-dimensional tissue model. 
